Replimune REPL
NASDAQ REPL
$13.45 +0.21 (+1.59%)
At close: Oct 1, 2026 · 4:00 PM EDT

Replimune (REPL) Other Accumulated Expenses (2018 - 2021)

Updated

Replimune (REPL) reported Other Accumulated Expenses of $514,000 for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 69.6% from $303,000 a year earlier but down 1.0% from the prior quarter.

Analysis

Replimune (REPL) Other Accumulated Expenses (2018 - 2021) Analysis & Trends

Dating back to fiscal Q4 2018, Replimune's Other Accumulated Expenses record includes 13 quarters.

  • Other Accumulated Expenses has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 49.8% (FY2018 to FY2021).
  • By fiscal year, Other Accumulated Expenses came in at $303,000 in FY2020 (+11.0%), $273,000 in FY2019 (+78.4%) and $153,000 in FY2018.
  • Five-year quarterly Other Accumulated Expenses spans a low of $129,000 in fiscal Q1 2019 and a high of $974,000 in fiscal Q2 2021.
  • Year over year, Other Accumulated Expenses has now increased in each of the last nine quarters, with growth averaging 106.4% over the last eight quarters.
  • Across the past five years, year-over-year growth in Other Accumulated Expenses ran from 2.3% in fiscal Q1 2020 to 335.6% in fiscal Q1 2021.
  • Per Business Quant data, the three fiscal quarters before Q4 2021 came in at $519,000 (Q3 2021), $974,000 (Q2 2021) and $575,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Replimune 1.11 Bn 1.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 514,000.00
Dec 31, 2020 519,000.00
Sep 30, 2020 974,000.00
Jun 30, 2020 575,000.00
Mar 31, 2020 303,000.00
Dec 31, 2019 345,000.00
Sep 30, 2019 608,000.00
Jun 30, 2019 132,000.00
Mar 31, 2019 273,000.00
Dec 31, 2018 251,000.00
Sep 30, 2018 158,000.00
Jun 30, 2018 129,000.00
Mar 31, 2018 153,000.00
API Access

Replimune Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY